a public good project by the
Synthesis
Company
of California

© 2026

Patricia Harlow | doi.page

0 works0 citations0 h-index

Patricia Harlow

DuPont (United States)(US)Merck (Germany)(DE)Wilmington University(US)Merck (United Kingdom)(GB)Experimental Station(US)

Publications by Year

Research Areas

RNA and protein synthesis mechanisms, Trace Elements in Health, Corrosion Behavior and Inhibition, CRISPR and Genetic Engineering, Pharmacogenetics and Drug Metabolism

Most-Cited Works

→ Human cytomegalovirus US3 and UL36-38 immediate-early proteins regulate gene expression(1992)131 cited
→ Isoxazolines as Potent Antagonists of the Integrin α_vβ₃(1999)85 cited
→ Disubstituted Indazoles as Potent Antagonists of the Integrin α_vβ₃(1999)72 cited
→ Structure, spatial, and temporal expression of two sea urchin metallothionein genes, SpMTB1 and SpMTA.(1991)51 cited
→ Structure of an ectodermally expressed sea urchin metallothionein gene and characterization of its metal-responsive region.(1989)48 cited
→ Developmental and tissue-specific regulation of beta-tubulin gene expression in the embryo of the sea urchin Strongylocentrotus purpuratus.(1987)39 cited

→ Coordinate and selective beta-tubulin gene expression associated with cilium formation in sea urchin embryos.(1987)

24 cited

→ Combinatorial Regulation by Promoter and Intron 1 Regions of the Metallothionein SpMTA Gene in the Sea Urchin Embryo(1993)23 cited

→ Warfarin Analog Inhibition of Human CYP2C9-Catalyzed S-Warfarin 7-Hydroxylation(1997)17 cited

→ Effect of 5,6-dichloro-1-β-d-ribofuranosyl benzimidazole on ribonucleotide metabolism and accumulation of mitochondrial RNA and low-molecular-weight cytoplasmic RNA in HeLa cells(1980)17 cited